Pinnacle Financial Partners (Tennessee)’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-730	Closed	-$48.2K	–	526
2024 Q4	$48.2K	Hold	730	–	–	﹤0.01%	482
2024 Q3	$48.2K	Sell	730 -800	-52%	-$58.1K	﹤0.01%	481
2024 Q2	$146K	Sell	1,530 -2,510	-62%	-$222K	﹤0.01%	444
2024 Q1	$386K	Buy	4,040 +2,510	+164%	+$211K	0.01%	346
2023 Q4	$117K	Hold	1,530	–	–	﹤0.01%	425
2023 Q3	$106K	Sell	1,530 -2,563	-63%	-$206K	﹤0.01%	405
2023 Q2	$386K	Buy	4,093 +2,563	+168%	+$223K	0.01%	322
2023 Q1	$127K	Hold	1,530	–	–	﹤0.01%	396
2022 Q4	$114K	Hold	1,530	–	–	﹤0.01%	388
2022 Q3	$126K	Buy	+1,530	New	+$147K	﹤0.01%	368
2022 Q2	–	Sell	-435	Closed	-$51K	–	439
2022 Q1	$51K	Hold	435	–	–	﹤0.01%	384
2021 Q4	$56K	Sell	435 -220	-34%	-$25.7K	﹤0.01%	411
2021 Q3	$74K	Buy	655 +220	+51%	+$25.1K	﹤0.01%	390
2021 Q2	$45K	Buy	+435	New	+$41K	﹤0.01%	397
2019 Q1	–	Sell	-4,137	Closed	-$211K	–	456
2018 Q4	$211K	Sell	4,137 -1,122	-21%	-$56.8K	0.02%	305
2018 Q3	$305K	Buy	5,259 +3,759	+251%	+$184K	0.03%	275
2018 Q2	$73K	Buy	+1,500	New	+$70K	0.01%	328
2017 Q3	–	Sell	-1,050	Closed	-$41K	–	329
2017 Q2	$41K	Buy	+1,050	New	+$38.3K	0.01%	355